Peter J Pappas
Overview
Explore the profile of Peter J Pappas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
935
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gadhoke N, Deol Z, Kennedy R, Lakhanpal S, Pappas P
Phlebology
. 2025 Jan;
:2683555251317852.
PMID: 39880021
Objective: CEAP categorizes patients based on disease progression and severity. Whether disease severity is associated with specific patterns of reflux is currently unknown. We hypothesize that patterns of reflux in...
2.
Trzesniowski A, Lakhanpal G, Sulakvelidze L, Kennedy R, Lakhanpal S, Pappas P
J Vasc Surg Venous Lymphat Disord
. 2024 Oct;
13(1):101990.
PMID: 39423912
Background: We previously reported that in women with symptomatic pelvic venous insufficiency secondary to combined iliac vein stenosis (IVS) and ovarian vein reflux (OVR), treated with iliac vein stenting alone...
3.
Nguyen D, Pappas K, Mahadevan S, Sulakvelidze L, Kennedy R, Lakhanpal G, et al.
Phlebology
. 2024 Aug;
40(2):80-87.
PMID: 39138919
Objective: Iliac vein stenting is the standard of care for patients with pelvic venous disorders secondary to symptomatic iliac vein outflow obstruction. Venous stents are often extended proximally into the...
4.
Gadhoke N, Bahethi S, Lakhanpal G, Sulakvelidze L, Kennedy R, Lakhanpal S, et al.
Phlebology
. 2024 May;
39(8):543-549.
PMID: 38798173
In 2021, the American Vein and Lymphatic Society convened a multi-disciplinary group to develop a valid and reliable discriminative instrument for the classification of patients suffering from pelvic venous disorders...
5.
Vemuri C, Gibson K, Pappas P, Sadek M, Ting W, Obi A, et al.
J Vasc Surg Venous Lymphat Disord
. 2023 Nov;
12(2):101700.
PMID: 37956904
Objective: Effective treatment options are available for chronic venous insufficiency associated with superficial venous reflux. Although many patients with C2 and C3 disease based on the CEAP (Clinical-Etiological-Anatomical-Pathophysiological) classification have...
6.
Calcagno T, Sulakvelidze L, Kennedy R, Christophi C, Lakhanpal G, Lakhanpal S, et al.
J Vasc Surg Venous Lymphat Disord
. 2023 Jul;
11(6):1213-1218.
PMID: 37453549
Background: In patients with pelvic venous disorders secondary to pelvic venous insufficiency (PVI), the optimal imaging modality is ill-defined. Transabdominal ultrasound (TAU) is widely used to identify the presence of...
7.
Pappas J, Pappas P, Lakhanpal S, Kennedy R, Soto T
J Vasc Surg Venous Lymphat Disord
. 2023 Jun;
11(5):938-945.
PMID: 37353153
Objective: The natural history of endovenous glue-induced thrombus (EGIT) resolution and the role of anticoagulation (AC) and/or anti-platelet (AP) agents in their management is currently ill-defined. The goal of this...
8.
Snow C, Pappas S, Sulakvelidze L, Kennedy R, Lakhanpal S, Pappas P
Phlebology
. 2022 Nov;
38(1):44-50.
PMID: 36440624
Introduction: Endovascular stenting is the standard of care for the management of symptomatic chronic venous obstruction. The increased radial resistive force and longer lengths of Nitinol stents have led to...
9.
Sulakvelidze L, Lakhanpal G, Lakhanpal S, Kennedy R, Lakhanpal R, Pappas P
J Vasc Surg Venous Lymphat Disord
. 2022 Oct;
11(2):357-364.
PMID: 36182087
Objective: The Wallstent (WS; Boston Scientific, Malborough, MA) is currently the standard of care for comparisons of clinical efficacy for new stent devices in the treatment of iliac vein outflow...
10.
Pappas P, Lakhanpal G, Lakhanpal S, Sulakvelidze L, Tran M, Shetty A, et al.
J Vasc Surg Venous Lymphat Disord
. 2021 Nov;
10(3):633-639.e1.
PMID: 34781006
Background: Many clinicians will prescribe anticoagulation therapy for patients after iliac vein stenting to prevent early or late stent thrombosis. At present, it is unknown whether therapeutic anticoagulation has any...